3-(2-carboxyindol-3-yl)propionic acid has been researched along with Progeria in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Daily, N; Elson, J; Wakatsuki, T | 1 |
1 other study(ies) available for 3-(2-carboxyindol-3-yl)propionic acid and Progeria
Article | Year |
---|---|
Aging Model for Analyzing Drug-Induced Proarrhythmia Risks Using Cardiomyocytes Differentiated from Progeria-Patient-Derived Induced Pluripotent Stem Cells.
Topics: Aging; Animals; Induced Pluripotent Stem Cells; Myocytes, Cardiac; Pharmaceutical Preparations; Progeria | 2023 |